As reported by Cattrini et al. [40], AXL was significantly correlated with BTLA, CD244, CD274, CTLA4 and other immune checkpoint molecules in ccRCC, indicating the vital roles of AXL in immunotherapy. This evidence concerns the gene CTLA4 and nonpapillary renal cell carcinoma.